A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of 100 mcg of Env 2-3 in MF59

Name: A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of 100 mcg of Env 2-3 in MF59
License: Public Domain

National Institute of Allergy and Infectious Diseases (NIAID) · clinicaltrials

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

hiv-infections

hiv infections, hiv seronegativity

ClinicalTrials.gov Show glossary Search for terms Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.

Record · ID 28426 · SHA-256 17c3746fc8cd5ac2
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.